![]() | |
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
PubChem CID | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C28H30N2O |
Molar mass | 410.561 g·mol−1 |
3D model (JSmol) | |
| |
|
Cumyl-BC-HpMeGaClone-221 (Cumyl-NBMeGaClone [1] , Cumyl-BC[2.2.1]HpMeGaClone, SGT-271) is a gamma-carboline derivative which is a synthetic cannabinoid that has been sold as a designer drug. [2] It was first identified in Germany in September 2020. [3]
Receptor (ligands) |
| ||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Transporter (modulators) |
| ||||||||||||||||||||||||||||||
Enzyme (modulators) |
| ||||||||||||||||||||||||||||||
Others |
| ||||||||||||||||||||||||||||||
|
![]() | This cannabinoid related article is a stub. You can help Wikipedia by expanding it. |